Queensland life sciences
research institution directory

Queensland Brain Institute (QBI), home to 250 researchers, all working to unlock the mysteries of the brain to generate new knowledge, understand learning and memory, develop new technologies to improve lives, and diagnose and treat brain disease and mental health. Support our exciting research.

The Centre for Advanced Imaging (CAI) within AIBN, is at the forefront of imaging science and is the only centre of its kind in Australia. Bringing together a critical mass of researchers and state-of-the-art preclinical and clinical research infrastructure and instruments, CAI enables world-class research through collaborations with industry and academia while fostering a rich, collaborative environment for our own experts to innovate across spectroscopic and imaging technologies. The CAI’s work is fundamental to a broad range of research fields, from major diseases affecting various organ systems, such as neurodegenerative disorders, cancer, and cardiovascular disease, through to imaging economically significant agricultural animals and plant material, minerals and construction materials. Through techniques such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Nuclear Magnetic Resonance (NMR) and Electron Paramagnetic Resonance (EPR) spectroscopy, as well as the state-of-the-art isotope production and radiochemistry capability within the centre, our researchers gain unique insights into the structure and function of biomolecules through to whole organisms. CAI’s impact on translational research is maximised through collaboration with clinical research sites and other local, national, and international research institutes. This gives CAI a comprehensive ‘end-to-end’ biomedical imaging capability which allows integrated progression from the laboratory bench, all the way through to a clinical setting.

CCRM Australia is the Australian Hub of the highly successful Centre for Commercialization of Regenerative Medicine in Canada (CCRM). Established as a not-for-profit with a national focus, CCRM Australia’s mission is to address bottlenecks in the translation and commercialisation of regenerative medicine discoveries in Australia

PRAXIS Australia is leading national and international education and training provider of high-quality, relevant and accessible training to build the confidence and capability of those working in clinical trials, research and ethics. Their offers have been built upon Harvard Multi-Regional Trials Centre competencies and aligned to NHMRC competencies. These training offers are a benchmark for research and clinical trials professionals in Australia, New Zealand, Asia Pacific Region, Europe, and the United States.

The Australian Institute of Tropical Health and Medicine (AITHM) is a flagship research institute of James Cook University based in the tropics of northern Australia. Australia’s only dedicated tropical health and medicine research institute, AITHM is focussed on solving problems of importance to the tropics, leading to improvements in health systems and healthcare delivery, improved biosecurity, and enhanced health outcomes for Australians and our neighbouring tropical nations.

The aims of the Centre for Genomics and Personalised Health are to translate knowledge from genomics research to improve human health, by discovering better methods of diagnosing disease, developing targeted treatments based on genetics, and training the next generation of translational genomics scientists.

The Gold Coast Health and Knowledge Precinct is a global business destination recognised for transforming lives through healthcare innovation, new knowledge and next-generation technologies.

Compounds Australia, located within the Griffith Institute for Drug Discovery, provides cost-effective sample management and logistics throughout the drug discovery pipeline. By securely storing and curating sample libraries, we allow translational health researchers worldwide to outsource their sample and natural product logistics and focus on results.

A young, fresh university driven by an unwavering belief that community and culture is just as important as a world-class education, delivered by world-class educators. We may not be the biggest university, but we’re growing fast, and doing big things. Like ground-breaking research, championing sustainability, producing gold-winning athletes and award-winning alumni. Our first campus, on the Sun

NuNerve Pty Ltd collaborates with scientists from the University of Queensland to develop a drug candidate for treating motor neurone disease (MND). The drug blocks the EphA4 protein, which plays a crucial role in motor neuron guidance and inhibiting their recovery after injury. This discovery has implications for MND, spinal cord injury, and other neurological diseases, offering a potential treatment for MND patients. NuNerve aims to manufacture the drug for upcoming clinical trials, prioritizing communication through healthcare professionals and providing updates via the QBI website and newsletter. Their urgent goal is to find a cure or disease-modifying strategy for MND.

Our formal name is Queensland Cane Growers Organisation Ltd (QCGO) but everyone knows us as CANEGROWERS. We have been advancing and protecting the interests of cane farming families in Queensland since 1926. CANEGROWERS is a not-for-profit public company providing a professional and cohesive voice for the members of 13 local grower companies, located in all of the sugarcane regions of Queensland.

Micromune Therapeutics is a startup aiming to develop a small molecule therapeutic for inflammatory bowel disease derived from the microbiome. This builds on research by Mater Research Institute-UQ Associate Professor Jakob Begun and UQ’s Institute for Molecular Bioscience’s Professor Rob Capon.

The $70 million UQ Centre for Clinical Research (CCR) at the Royal Brisbane and Women's Hospital (RBWH) is focused on improving people's lives through patient-orientated research. Offer state-of-the-art facilities and bring together leading health professionals, clinicians and scientists from around the globe.

Vast Bioscience is a privately owned biotechnology company established to exploit a proprietary technology platform called VAST (Versatile Assembly on Stable Templates). Vast offers the pharmaceutical industry a unique opportunity to develop innovative drugs with superior potency, target selectivity and safety.

Established in 1994 by a group of dedicated doctors, Wesley Research Institute is Queensland’s second-oldest medical research institute. Wesley Research Institute aims to improve patient outcomes by linking medical and health research to clinical outcomes.

The Queensland Emory Drug Discovery Initiative (QEDDI) is a unique small molecule drug discovery and development group operating within an Australian university, UniQuest. Their mission is to bridge the gap between academic biomedical research and the development of new medicines. With an industry-experienced team, QEDDI focuses on advancing biomedical research into promising drug candidates to facilitate commercial partnerships and expedite drug development. They possess core capabilities and expertise in medicinal chemistry, compound screening, and profiling, enabling them to drive the discovery of innovative therapeutics.

PEF's vision is to be a world leader in protein research services, technologies and training. PEF has a team of high-performing research specialists providing research capabilities and expertise on recombinant protein production.

The University of Queensland is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.UQ is consistently ranked among the world's top 50 universities. In the 2022 Aggregate Ranking of Top Universities, UQ ranked 2nd in Australia and 42nd in the world.

The University of Southern Queensland (USQ) is a young, dynamic university. USQ has campuses in the regional centres of Toowoomba, Springfield and Ipswich. USQ is internationally recognised for delivering practical, world-class research that delivers high-impact solutions.

The UltraThera is a non-invasive, incisionless, and radiation-free medical device developed by researchers at The University of Queensland's Queensland Brain Institute. It uses low-frequency transcranial scanning ultrasound to treat brain diseases like Alzheimer's. By overcoming the blood-brain barrier, it enables a multi-modal therapeutic approach to address treatment limitations and facilitate the development of effective treatments.

The Translational Research Institute (TRI) is an Australian initiative focused on advancing medical research from the laboratory to the community. Combining clinical and translational research, TRI aims to enhance detection, diagnosis, and treatment methods for various health conditions, ultimately improving patient outcomes. Their work spans across different areas, including cancer, autoimmune diseases, and more, with a focus on developing innovative treatments and diagnostics that can be translated into better healthcare practices.

UniQuest is Australia’s leading commercialisation entity, specialising in commercialising the intellectual property of The University of Queensland, a global top 50 university. Uniquest benchmarks in the top tier of technology transfer worldwide.

Queensland University of Technology (QUT) is a renowned Australian university that emphasizes a global perspective. With nearly 50,000 students, QUT offers real-world infrastructure, education, and graduate skills to empower the next generation of change-makers. Collaborating with various universities, institutions, and hospitals, QUT is dedicated to research excellence. Their research team is highly regarded for providing government, businesses, and organizations with top-notch research resources. QUT houses cutting-edge facilities and research groups focused on innovative research across various health disciplines. QUT is home to the Centre for Genomics and Personalised Health, contributing to advancements in personalized medicine.

Established in 2003, the Queensland Brain Institute is a leading research institute focused on two of the greatest challenges of modern science: understanding brain function, and preventing and treating disorders of brain function.

Mater Research is a recognised leader in medical research. Mater Research works across Mater Health’s hospitals and health services, the University of Queensland, and the world- class Translational Research Institute.

The Queensland Eye Institute is one of the world’s finest centres for eye health, medical research, education and care. It is Queensland’s largest independent academic research institute devoted to eye related health and diseases.

QIMR Berghofer Medical Research Institute is a world- leading translational research institute where research develops from the laboratory bench to the patient’s bedside. With almost 900 scientists, students and support staff, and more than 50 state-of-the-art laboratories, QIMR Berghofer is one of Australia’s largest and most successful institutes.

James Cook University (JCU) is one of the world’s leading institutions focusing on the tropics. With main campuses in the tropical cities of Townsville, Cairns and Singapore, JCU’s teaching and research are shaped by the university’s presence in Asia and its proximity to the wet tropics, dry savannahs and iconic great Barrier Reef. JCU’s focus is on the health, environment and populations of tropical regions. JCU has the Australian Institute of Tropical Health & Medicine and the Queensland Tropical Health Alliance.

The University of Queensland's Institute for Molecular Bioscience (IMB) is a renowned global leader in multidisciplinary life sciences research. With a team of 500 researchers from around the world, IMB focuses on disease discovery, application, and sustainable futures. Their research has resulted in the creation of 12 successful spin-out companies, generating international impact and attracting substantial investments to Queensland. IMB is a preferred partner for national and international pharmaceutical, biotech, and agricultural companies, leading to significant collaborations, including Australia's largest biotech deal and contributing to 50% of UQ's patent income.The University of Queensland's Institute for Molecular Bioscience (IMB) is a renowned global leader in multidisciplinary life sciences research. With a team of 500 researchers from around the world, IMB focuses on disease discovery, application, and sustainable futures. Their research has resulted in the creation of 12 successful spin-out companies, generating international impact and attracting substantial investments to Queensland. IMB is a preferred partner for national and international pharmaceutical, biotech, and agricultural companies, leading to significant collaborations, including Australia's largest biotech deal and contributing to 50% of UQ's patent income.

Griffith University's Clinical Trial Unit, located within the Gold Coast Health and Knowledge Precinct and adjacent to the Gold Coast University Hospital, provides state-of-the-art facilities and professional coordination services to phase I-IV clinical trials. Supporting university staff and collaborators to conduct a wide range of trials, but also offering professional clinical trial site services to commercial clients such as global pharma, contract research organisations and the biotech and nutraceutical industry.

The Menzies Health Institute Queensland (MHIQ) conducts research to understand health factors and develop strategies for improving wellbeing. Their three programs focus on Disability and Rehabilitation, Healthcare Practice and Survivorship, and Infectious Diseases and Immunology, aligning with health priorities. With additional resources like a Clinical Trial Unit, Gold Coast BioBank, and expertise in biostatistics and health economics, MHIQ emphasizes innovation, research translation, and collaborations with clinical and community partners. Their aim is to enhance health and quality of life for individuals, families, and communities.

Griffith University is ranked amongst the top 3% of universities globally, and has over 50,000 students spread across 5 campuses. Griffith’s health and bioscience research institutes collaborate with industry and public health sectors to deliver global benefits through outcomes such as novel drug leads, vaccines for combating infectious diseases, and healthy living programs.

The Australian Institute for Bioengineering and Nanotechnology is an integrated multidisciplinary research institute bringing together world-class researchers and cutting-edge technology with a focus on translational research.

Bond University has always dared to be different. Our founders’ vision was to create a bold educational experience that opened new doors to opportunities and transformed the career trajectories of its graduates. Bond was envisioned as a place where all students could learn from world-class industry leaders, be personally mentored by their teachers, and have access to cutting-edge technologies, equipment and resources.

Experienced, tailored consulting in Research, Development and Innovation. We have been engaged with the Australian research ecosystem for over 20 years and understand the research funding landscape and the industry. Our consultants have advanced qualifications in their research field, experience working in that field, as well as consulting, business, legal and/or governance experience. Our combination of technical and business skills are critical to our approach. We prioritise positive, timely and accurate communication and high quality outputs.